Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rimland

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Antimicrobial Agents and Chemotherapy|February 1, 1997
Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase geneL Stuyver, A Wyseur, A Rombout, et al.
The Journal of Infectious Diseases|December 23, 1999
Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virusT R Navin, D Rimland, J L Lennox, et al.
Archives of Internal Medicine|April 1, 1988
The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing homeN H Arden, P A Patriarca, M B Fasano, et al.
Infection Control and Hospital Epidemiology|July 1, 1997
Nosocomial infections in HIV-infected patients: preliminary results from a multicenter surveillance system (1989-1995)L Stroud, P Srivastava, D Culver, et al.
AIDS (London, England)|December 13, 2001
Prospective study of etiologic agents of community-acquired pneumonia in patients with HIV infectionD Rimland, T R Navin, J L Lennox, et al.
Antimicrobial Agents and Chemotherapy|January 30, 1999
A rapid non-culture-based assay for clinical monitoring of phenotypic resistance of human immunodeficiency virus type 1 to lamivudine (3TC)J García Lerma, R F Schinazi, A S Juodawlkis, et al.
AIDS (London, England)|July 14, 2000
Effect of clinical events on plasma HIV-1 RNA levels in persons with CD4+ T-lymphocyte counts of more than 500 x 10(6) cells/lL E Chapman, T A Green, F Ahmed, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998M E Brandt, M A Pfaller, R A Hajjeh, et al.
American Journal of Infection Control|February 9, 1999
APIC position paper: immunization. Association for Professionals in Infection and Epidemiology, IncM G DeCastro, G A Denys, L L Fauerbach, et al.
American Journal of Infection Control|February 9, 1999
APIC position paper: hepatitis C exposure in the health care setting. Association for Professionals in Infection Control and Epidemiology, IncM G DeCastro, G A Denys, L L Fauerbach, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|February 1, 1997
Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase geneL Stuyver, A Wyseur, A Rombout, et al.
The Journal of Infectious Diseases|December 23, 1999
Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virusT R Navin, D Rimland, J L Lennox, et al.
Archives of Internal Medicine|April 1, 1988
The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing homeN H Arden, P A Patriarca, M B Fasano, et al.
Infection Control and Hospital Epidemiology|July 1, 1997
Nosocomial infections in HIV-infected patients: preliminary results from a multicenter surveillance system (1989-1995)L Stroud, P Srivastava, D Culver, et al.
AIDS (London, England)|December 13, 2001
Prospective study of etiologic agents of community-acquired pneumonia in patients with HIV infectionD Rimland, T R Navin, J L Lennox, et al.
Antimicrobial Agents and Chemotherapy|January 30, 1999
A rapid non-culture-based assay for clinical monitoring of phenotypic resistance of human immunodeficiency virus type 1 to lamivudine (3TC)J García Lerma, R F Schinazi, A S Juodawlkis, et al.
AIDS (London, England)|July 14, 2000
Effect of clinical events on plasma HIV-1 RNA levels in persons with CD4+ T-lymphocyte counts of more than 500 x 10(6) cells/lL E Chapman, T A Green, F Ahmed, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998M E Brandt, M A Pfaller, R A Hajjeh, et al.
American Journal of Infection Control|February 9, 1999
APIC position paper: immunization. Association for Professionals in Infection and Epidemiology, IncM G DeCastro, G A Denys, L L Fauerbach, et al.
American Journal of Infection Control|February 9, 1999
APIC position paper: hepatitis C exposure in the health care setting. Association for Professionals in Infection Control and Epidemiology, IncM G DeCastro, G A Denys, L L Fauerbach, et al.
Pageof 8